In addition, the transduction of CML-DC by CD40 targeted Ad vectors could serve as an ideal means to introduce cytokine transgenes for the induction of a more potent immune response and a prolonged survival of CML-DC. The gene discussed is CD40; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.